INDENOPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
Provided are an indenopyridine-based compound and an organic light-emitting device including the same. The indenopyridine-based compound is represented by Formula 1:
Korean Patent Application No. 10-2013-0104502, filed on Aug. 30, 2013, in the Korean Intellectual Property Office, and entitled: “Indenopyridine-Based Compound and Organic Light-Emitting Device Including The Same,” is incorporated by reference herein in its entirety.
BACKGROUND1. Field
One or more embodiments relate to an indenopyridine-based compound and an organic light-emitting device including the same.
2. Description of the Related Art
Organic light-emitting devices (OLEDs) are self-emitting devices that may have wide viewing angle, excellent contrast, quick response, high brightness, and excellent driving voltage, and can provide multicolored images.
SUMMARYEmbodiments are directed to an indenopyridine-based compound represented by Formula 1:
wherein, in Formula 1,
X1 is a nitrogen atom (N) or C(R11); X2 is N or C(R12); X3 is N or C(R13); X4 is N or C(R14); wherein at least one of X1 to X4 is N;
L1 is selected from a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C6-C60 arylene group, a substituted or unsubstituted C2-C10 heterocycloalkylene group, a substituted or unsubstituted C2-C10 heterocycloalkenylene group, and a substituted or unsubstituted C2-C60 heteroarylene group;
n1 is selected from an integer of 0, 1, 2, and 3;
R1 and R2 are each independently selected from a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, a carboxyl group, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C2-C30 alkenyl group, a substituted or unsubstituted C2-C30 alkynyl group, a substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C6-C30 arylthio group, and a substituted or unsubstituted C2-C30 heteroaryl group, wherein R1 and R2 are optionally connected to each other to form a substituted or unsubstituted C6-C20 saturated ring or a substituted or unsubstituted C6-C20 unsaturated ring;
R11 to R14, R3, and R4 are each independently selected from a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, a carboxyl group, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C2-C30 alkenyl group, a substituted or unsubstituted C2-C30 alkynyl group, a substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C6-C30 arylthio group, and a substituted or unsubstituted C2-C30 heteroaryl group; and
a1 and a2 are each independently selected from an integer of 0, 1, 2 and 3.
Also provided is an organic light-emitting device (OLED), including a first electrode; a second electrode facing the first electrode; and an organic layer that is disposed between the first electrode and the second electrode and includes an emission layer. The organic layer includes at least one indenopyridine-based compound represented by Formula 1.
Features will become apparent to those of skill in the art by describing in detail exemplary embodiments with reference to the attached drawings in which:
Example embodiments will now be described more fully hereinafter with reference to the accompanying drawings; however, they may be embodied in different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey exemplary implementations to those skilled in the art.
In the drawing figures, the dimensions of layers and regions may be exaggerated for clarity of illustration. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items. Expressions such as “at least one of,” when preceding a list of elements, modify the entire list of elements and do not modify the individual elements of the list.
Provided is an indenopyridine-based compound represented by Formula 1:
In Formula 1, X1 is N or C(R11); X2 is N or C(R12); X3 is N or C(R13); X4 is N or C(R14); wherein at least one of X1 to X4 may be N.
In one embodiment, in Formula 1, X1 may be N; X2 may be C(R12); X3 may be C(R13); and X4 may be C(R14).
In another embodiment, in Formula 1, X1 may be C(R11); X2 may be N; X3 may be C(R13); and X4 may be C(R14).
In another embodiment, in Formula 1, X1 may be C(R11); X2 may be C(R12); X3 may be N; and X4 may be C(R14).
In another embodiment, in Formula 1, X1 may be C(R11); X2 may be C(R12); X3 may be C(R13); and X4 may be N.
In Formula 1, L1 may be selected from a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C6-C60 arylene group, a substituted or unsubstituted C2-C10 heterocycloalkylene group, a substituted or unsubstituted C2-C10 heterocycloalkenylene group, and a substituted or unsubstituted C2-C60 heteroarylene group.
In one embodiment, in Formula 1, L1 may be selected from:
i) a C3-C10 cycloalkylene group, a C3-C10 cycloalkenylene group, a C6-C60 arylene group, a C2-C10 heterocycloalkylene group, a C2-C10 heterocycloalkenylene group, and a C2-C60 heteroarylene group; and
ii) a C3-C10 cycloalkylene group, a C3-C10 cycloalkenylene group, a C6-C60 arylene group, a C2-C10 heterocycloalkylene group, a C2-C10 heterocycloalkenylene group, and a C2-C60 heteroarylene group, each substituted with at least one selected from
a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, and a C1-C10 alkyl group;
a C1-C10 alkyl group substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphoric acid group or a salt thereof;
a C6-C16 aryl group and a C2-C16 heteroaryl group; and
a C6-C16 aryl group and a C2-C16 heteroaryl group, each substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C6-C16 aryl group, and a C2-C16 heteroaryl group.
In another embodiment, in Formula 1, L1 may be selected from:
i) a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphtylene group, a fluorenylene group, a spiro-fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pyrrolylene group, an imidazolylene group, a pyrazolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, an indazolylene group, a purinylene group, a quinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a carbazolylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzooxazolylene group, a benzoimidazolylene group, a furanylene group, a benzofuranylene group, a thiophenylene group, a benzothiophenylene group, a thiazolylene group, an isothiazolylene group, a benzothiazolylene group, an isooxazolylene group, an oxazolylene group, a triazolylene group, a tetrazolylene group, an oxzdiazolylene group, a triazinylene group, a benzooxazolylene group, a dibenzofuranylene group, a dibenzothiophenylene group, and a benzocarbazolyl group; and
ii) a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphtylene group, a fluorenylene group, a spiro-fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pyrrolylene group, an imidazolylene group, a pyrazolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, an indazolylene group, a purinylene group, a quinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a carbazolylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzooxazolylene group, a benzoimidazolylene group, a furanylene group, a benzofuranylene group, a thiophenylene group, a benzothiophenylene group, a thiazolylene group, an isothiazolylene group, a benzothiazolylene group, an isooxazolylene group, an oxazolylene group, a triazolylene group, a tetrazolylene group, an oxzdiazolylene group, a triazinylene group, a benzooxazolylene group, a dibenzofuranylene group, a dibenzothiophenylene group, and a benzocarbazolyl group, each substituted with at least one selected from
a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, and a C1-C10 alkyl group;
a C1-C10 alkyl group substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphoric acid group or a salt thereof;
a C6-C16 aryl group and a C2-C16 heteroaryl group; and
a C6-C16 aryl group and a C2-C16 heteroaryl group, each substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C6-C16 aryl group, and a C2-C16 heteroaryl group.
In another embodiment, in Formula 1, L1 may be selected from:
i) a phenylene group, a naphthylene group, an anthracenylene group, a chrysenylene group, and a pyrenylene group; and
ii) a phenylene group, a naphthylene group, an anthracenylene group, a chrysenylene group, and a pyrenylene group, each substituted with at least one selected from
a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, and a C1-C10 alkyl group;
a C1-C10 alkyl group substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphoric acid group or a salt thereof;
a C6-C16 aryl group and a C2-C16 heteroaryl group; and
a C6-C16 aryl group and a C2-C16 heteroaryl group, each substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C6-C16 aryl group, and a C2-C16 heteroaryl group.
In another embodiment, in Formula 1, L1 may be selected from:
i) a phenylene group, an anthracenylene group, a chrysenylene group, and a pyrenylene group; and
ii) a phenylene group, an anthracenylene group, a chrysenylene group, and a pyrenylene group, each substituted with at least one selected from
a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, and a tert-butyl group;
a phenyl group, a naphthyl group, a pyridyl group, and a triazinyl group; and
a phenyl group, a naphthyl group, a pyridyl group, and a triazinyl group, each substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, and a tert-butyl group.
In another embodiment, in Formula 1, L1 may be selected from a phenylene group, an anthracenylene group, a chrysenylene group, and a pyrenylene group.
In Formula 1, n1 denotes the number of L1, and n1 is an integer of 0 to 3. When n1 is an integer of 2 or greater, L1 s may be identical to or different from each other.
In some embodiments, in Formula 1, n1 may be an integer of 1 or 2.
In one embodiments, in Formula 1, a moiety represented by (L1)n1 may be one selected from Formulae 2-1 to 2-4:
In Formulae 2-1 to 2-4,
Y1 to Y7 are each independently selected from
i) a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, and a tert-butyl group;
ii) a phenyl group, a naphthyl group, a pyridyl group, and a triazinyl group; and
iii) a phenyl group, a naphthyl group, a pyridyl group, and a triazinyl group, each substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, and a tert-butyl group;
b1 to b7 are each independently an integer of 0 to 4;
* is a binding site with R4; and
** is a binding site with an indenopyridine ring.
In another embodiment, in Formula 1, a moiety represented by (L1)n1 may be one selected from Formulae 2-1 to 2-4:
In Formulae 2-1 to 2-4,
Y1 to Y7 are each independently selected from
a hydrogen atom, a deuterium atom, a fluorine atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, a tert-butyl group, a phenyl group, a naphthyl group, a pyridyl group, and a triazinyl group;
b1 to b7 are each independently an integer of 0 or 1;
* is a binding site with R4; and
** is a binding site with an indenopyridine ring.
In another embodiment, in Formula 1, a moiety represented by (L1)n1 may be one selected from Formulae 3-1 to 3-4:
In Formulae 3-1 to 3-4,
* is a binding site with R4; and
** is a binding site with an indenopyridine ring.
In Formula 1, R1 and R2 may each independently be selected from a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, a carboxyl group, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C2-C30 alkenyl group, a substituted or unsubstituted C2-C30 alkynyl group, a substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C6-C30 arylthio group, and a substituted or unsubstituted C2-C30 heteroaryl group, wherein R1 and R2 may be optionally linked to each other and form a substituted or unsubstituted C6-C20 saturated ring or a substituted or unsubstituted C6-C20 unsaturated ring.
In one embodiment, in Formula 1, R1 and R2 are each independently selected from a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a substituted or unsubstituted C1-C10 alkyl group, and a substituted or unsubstituted C6-C16 aryl group, wherein R1 and R2 may be optionally linked to each other and form a substituted or unsubstituted C6-C20 saturated ring or a substituted or unsubstituted C6-C20 unsaturated ring.
In another embodiment, in Formula 1, R1 and R2 are each independently selected from a hydrogen atom, a deuterium atom, a fluorine atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, a tert-butyl group, a phenyl group, and a naphthyl group, wherein R1 and R2 may be optionally linked to each other and form an unsubstituted C6-C20 saturated ring or an unsubstituted C6-C20 unsaturated ring.
In another embodiment, in Formula 1, R1 and R2 may each independently be selected from a hydrogen atom, a deuterium atom, a methyl group, and a phenyl group, or R1 and R2 combined are Formula 5:
In Formula 5, * is a binding site with an indenopyridine ring.
In Formula 1, R11 to R14, R3, and R4 may each independently be selected from a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, a carboxyl group, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C2-C30 alkenyl group, a substituted or unsubstituted C2-C30 alkynyl group, a substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C6-C30 arylthio group, and a substituted or unsubstituted C2-C30 heteroaryl group.
In one embodiment, in Formula 1, R11 to R14 and R3 may each independently be selected from
i) a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, and a tert-butyl group;
ii) a phenyl group, a naphthyl group, a pyridyl group, and a triazinyl group; and
iii) a phenyl group, a naphthyl group, a pyridyl group, and a triazinyl group, each substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, and a tert-butyl group.
In another embodiment, in Formula 1, R11 to R14 and R3 may each independently be selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, and an iso-butyl group.
In another embodiment, in Formula 1, R11 to R14 and R3 may each independently be selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a nitro group, a methyl group, and a tert-butyl group.
In one embodiment, in Formula 1, R4 may be selected from a substituted or unsubstituted C6-C20 aryl group, and a substituted or unsubstituted C2-C20 heteroaryl group.
In another embodiment, in Formula 1, R4 may be selected from:
i) a C6-C20 aryl group and a C2-C20 heteroaryl group; and
ii) a C6-C20 aryl group and a C2-C20 heteroaryl group, each substituted with at least one selected from
a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, and a C1-C10 alkyl group;
a C1-C10 alkyl group substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphoric acid group or a salt thereof;
a C6-C16 aryl group and a C2-C16 heteroaryl group; and
a C6-C16 aryl group and a C2-C16 heteroaryl group, each substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C6-C16 aryl group, and a C2-C16 heteroaryl group.
In another embodiment, in Formula 1, R4 may be selected from:
i) a phenyl group, a pentalenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphtyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenathrenyl group, an anthryl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzooxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a benzooxazolyl group, a dibenzopuranyl group, a dibenzothiophenyl group, and a carbazolyl group; and
ii) a phenyl group, a pentalenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphtyl group, fluolenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenathrenyl group, an anthryl group, fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group. a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzooxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a benzooxazolyl group, a dibenzopuranyl group, a dibenzothiophenyl group, and a carbazolyl group, each substituted with at least one selected from
a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, and a C1-C10 alkyl group;
a C1-C10 alkyl group substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphoric acid group or a salt thereof;
a C6-C16 aryl group and a C2-C16 heteroaryl group; and
a C6-C16 aryl group and a C2-C16 heteroaryl group, each substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C6-C16 aryl group, and a C2-C16 heteroaryl group.
In another embodiment, in Formula 1, R4 may be selected from:
i) a phenyl group, a naphthyl group, and an anthryl group; and
ii) a phenyl group, a naphthyl group, and an anthryl group, each substituted with at least one selected from a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, a tert-butyl group, a phenyl group, a naphthyl group, and an anthryl group.
In another embodiment, in Formula 1, R4 may be selected from a phenyl group, 1-a naphthyl group, and 2-a naphthyl group.
In Formula 1, a1 is the number of R3 which may be an integer of 0 to 3. When a1 is an integer of 2 or greater, R3s may be identical to or different from each other.
In Formula 1, a2 is the number of R4 which may be an integer of 0 to 3. When a2 is an integer of 2 or greater, R4s may be identical to or different from each other.
In some embodiments, in Formula 1, a1 may be an integer of 0 or 1.
In some embodiments, in Formula 1, a2 may be an integer of 0 or 1.
In Formula 1, the number of moiety represented by [(R4)a2-(L1)n1] may be represented by (4-a1).
In one embodiment, a1 may be an integer of 2 or 3.
In another embodiment, a2 may be 1 or n1 may be 1, and a1 may be 3.
In one embodiment, the indenopyridine-based compound may be represented by Formula 1a:
wherein, in Formula 1a, a moiety represented by (L1)n1 may be one selected from Formulae 3-1 to 3-4:
wherein, in Formulae 3-1 to 3-4,
* is a binding site with R4; ** is a binding site with an indenopyridine ring; and
R1 and R2 are each independently selected from a hydrogen atom, a deuterium atom, a methyl group, and a phenyl group, or R1 and R2 combined are Formula 5:
wherein, in Formula 5,
-
- * is a binding site with an indenopyridine ring;
R3 and R12 to R14 are each independently selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a nitro group, and a methyl group;
R4 is selected from a phenyl group, a 1-naphthyl group, and a 2-naphthyl group;
a1 is 3; and
a2 is an integer of 0 or 1.
In another embodiment, the indenopyridine-based compound may be represented by one selected from Formulae 1b to 1e:
wherein, in Formulae 1b to 1e, a moiety represented by (L1)n1 is one selected from Formulae 3-1 to 3-4:
wherein, in Formulae 3-1 to 3-4,
* is a binding site with R4; ** is a binding site with an indenopyridine ring; and
R1 and R2 are each independently selected from a hydrogen atom, a deuterium atom, a methyl group, and a phenyl group, or R1 and R2 combined are Formula 5:
wherein, in Formula 5,
* is a binding site with an indenopyridine ring;
R13 is selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a nitro group, and a methyl group;
R4 is selected from a phenyl group, a 1-naphthyl group, and a 2-naphthyl group; and
a2 is an integer of 0 or 1.
In some embodiments, the indenopyridine-based compound may be selected from Compounds 1 to 25:
An indenopyridine-based compound represented by Formula 1 may have a high glass transition temperature (Tg) and excellent thermal stability, and an OLED including an indenopyridine-based compound represented by Formula 1 may have a thin film that exhibits high stability.
An indenopyridine-based compound represented by Formula 1 may increase a formation ratio of excitons by increasing a trapping ratio of holes and electrons in an OLED. Also, an indenopyridine-based compound represented by Formula 1 may have a relatively high resistance against a charge exposure, and an OLED including an indenopyridine-based compound represented by Formula 1 may have an improved efficiency and an improved lifespan.
An indenopyridine-based compound represented by Formula I may have a band gap that is narrower than that of a carbazole-based compound, and may help provide improved emission of fluorescent light compared to a carbazole-based compound. In addition, the indenopyridine-based compound may have excellent hole transporting properties, and the indenopyridine-based compound may help provide an OLED with an improved efficiency compared to a carbazole-based compound, which may hinder control of charge balance in an emission layer.
Also, an indenopyridine-based compound represented by Formula 1 may have a higher amorphous degree than a compound including pyridine, and the indenopyridine-based compound may produce excitons with better efficiency in an emission layer. An organic-light emitting device including the indenopyridine-based compound may have a relatively high efficiency.
Moreover, an indenopyridine-based represented by Formula 1 includes a nitrogen atom (N) in an indenopyridine ring, and charges may be easily trapped in the indenopyridine-based compound. Therefore, when the indenopyridine-based compound serves as a host, a large amount of charges trapped in the host may be transported to a dopant, and efficiency of the OLED may increase.
An indenopyridine-based compound represented by Formula 1 may be synthesized by using an organic synthesis method. The synthesis method of the indenopyridine-based compound may be easily understood by one of skill in the art with reference to examples, which will be described below.
As used herein, the expression “organic layer” refers to a single layer and/or multiple layers disposed between a first electrode and a second electrode of an OLED.
At least one indenopyridine-based compound represented by Formula 1 may be included in an organic layer disposed between a pair of electrodes of an OLED. For example, the at least one indenopyridine-based compound represented by Formula 1 may be included in an emission layer. The at least one indenopyridine-based compound represented by Formula 1 may serve as a host of the emission layer.
In an embodiment, provided is an OLED including a first electrode; a second electrode facing the first electrode; and an organic layer that is disposed between the first electrode and the second electrode and includes an emission layer, wherein the organic layer includes the indenopyridine-based compound represented by Formula 1.
As used herein, the expression “(the organic layer) may include at least one indenopyridine-based compound of Formula 1” may be understood as “(the organic layer) may include one indenopyridine-based compound represented by Formula 1 or at least two different compounds selected from indenopyridine-based compounds represented by Formula 1”.
In some embodiments, the organic layer may only include Compound 1 as the indenopyridine-based compound. For example, Compound 1 may be included in the emission layer of the organic light-emitting device. Alternatively, the organic layer may include Compound 1 and Compound 2 as the indenopyridine-based compound. For example, Compound 1 and Compound 2 may be included in the same layer or respectively included in two different layers (e.g., an emission layer or a first emission layer and a second emission layer).
A substrate 110 may be a substrate used in a general OLED, and may be a glass substrate or a transparent plastic substrate having excellent mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and waterproofness.
A first electrode 120 may be formed by applying a first electrode material on the substrate 110 by deposition or sputtering. In an embodiment, the first electrode 120 is an anode, and the first electrode material may be selected from materials having a high work function to facilitate hole injection. The first electrode 120 may be a reflective electrode or a transparent electrode. Examples of the first electrode material may include indium-tin oxide (ITO), Indium-zinc-oxide (IZO), tin oxide (SnO2), and zinc oxide (ZnO). Also, in an embodiment, magnesium (Mg), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), or magnesium-silver (Mg—Ag) is used as the first electrode material, and the first electrode 120 may be formed as a reflective electrode.
The first electrode 120 may be formed as a single layer or may have a multi-layered structure having at least two layers. For example, the first electrode 120 may have a three-layered structure, e.g., ITO/Ag/ITO.
An organic layer 130 is formed on the first electrode 120.
The organic layer 130 may sequentially include a hole injection layer (HIL) 131, a hole transport layer (HTL) 132, a H-functional layer, a buffer layer, an emission layer (EML) 133, an electron transport layer (ETL) 134, and an electron injection layer (EIL) 135.
The HIL 131 may be formed on the first electrode 120 by using various methods such as vacuum deposition, spin coating, casting, or LB deposition.
When the HIL 131 is formed by vacuum deposition, the deposition conditions may vary according to a compound used as a material for forming the HIL 131 and a structure and thermal characteristics of a desired HIL. For example, the deposition condition may be a deposition temperature of about 100 to about 500° C., a degree of vacuum of about 10−8 to about 10−3 torr, and a deposition speed of about 0.01 to about 100 Å/sec.
When the HIL 131 is formed by spin coating, the coating condition may vary according to a compound used as a material for forming the HIL 131, a structure of a desired HIL, and thermal characteristics. For example, the coating condition may be a coating speed of about 2,000 to about 5,000 rpm and a heat treatment temperature for removing a solvent after coating of about 80 to about 200° C.
Exemplary materials for forming the HIL 131 include N,N′-diphenyl-N,N′-bis-[4-(phenyl-m-tolyl-amino)-phenyl]-biphenyl-4,4′-diamine (DNTPD), a phthalocyanine compound such as copper phthalocyanine, 4,4′,4″-tris(3-methylphenylphenylamino) triphenylamine (m-MTDATA), N,N′-di(1-naphthyl)-N,N′-diphenylbenzidine (NPB), 4,4′,4″-tris(N,N-diphenylamino)triphenylamine) (TDATA), 4,4′,4″-tris[2-naphthyl(phenyl)amino]triphenylamine) (2-TNATA), polyaniline/dodecylbenzenesulfonic acid (PANI/DBSA), poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate) (PEDOT/PSS), polyaniline/camphor sulfonicacid (PANI/CSA), and polyaniline/poly(4-styrenesulfonate) (PANI/PSS):
A thickness of the HIL 131 may be in a range of about 100 Å to about 10,000 Å, for example, in a range of about 100 Å to about 1,000 Å. Maintaining a thickness of the HIL 131 within this range may help provide satisfactory hole injecting properties without a substantial increase in driving voltage.
Next, the HTL 132 may be formed on the HTL 131 by vacuum deposition, spin coating, casting, or LB deposition. When the HTL is formed by vacuum deposition or spin coating, the deposition and coating conditions vary depending on a used compound, but generally the conditions may be about the same as the conditions for forming the HIL 131.
Exemplary materials for forming the HTL 131 include carbazole derivatives, such as N-phenylcarbazole and polyvinylcarbazole, N,N′-bis(3-methylphenyl)-N,N′-diphenyl-[1,1-biphenyl]-4,4′-diamine (TPD), 4,4′,4″-tris(N-carbazolyl)triphenylamine (TCTA), and N,N′-di(1-naphthyl)-N,N′-diphenylbenzidine (NPB):
A thickness of the HTL 132 may be in a range of about 50 Å to about 2,000 Å, for example, in a range of about 100 Å to about 1,500 Å. Maintaining a thickness of the HTL 132 within this range may help provide satisfactory hole transporting properties without a substantial increase in driving voltage.
The H-functional layer (a functional layer having both hole injection and transport abilities) may include at least one of the HIL materials and the HTL materials stated above, and a thickness of the H-functional layer may be in a range of about 500 Å to about 10,000 Å, for example, in a range of about 100 Å to about 1,000 Å. Maintaining a thickness of the H-functional layer within this range may help provide satisfactory hole injecting and transporting properties without a substantial increase in driving voltage.
At least one of the HIL 131, the HTL 132, and the H-functional layer may include at least one of a compound represented by Formula 300 and a compound represented by Formula 350:
In Formulae 300 and 350, Ar11, Ar12, Ar21, and Ar22 are each independently a substituted or unsubstituted C5-C60 arylene group. Detailed descriptions about Ar11, Ar12, Ar21, and Ar22 may be referred to the detailed description of L1 stated above.
In Formula 300, e and f are each independently an integer of 0 to 5, for example, 0, 1, or 2. In one embodiment, e may be 1, and f may be 0.
In Formulae 300 and 350, R51 to R58, R61 to R69, R71, and R72 may each independently be a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C1-C60 alkyl group, a substituted or unsubstituted C2-C60 alkenyl group, a substituted or unsubstituted C2-C60 alkynyl group, a substituted or unsubstituted C1-C60 alkoxy group, a substituted or unsubstituted C3-C60 cycloalkyl group, a substituted or unsubstituted C5-C60 aryl group, a substituted or unsubstituted C5-C60 aryloxy group, or a substituted or unsubstituted C5-C60 arylthio group. In some embodiments, R51 to R58, R61 to R69, R71, and R72 may each independently be one of:
a hydrogen atom; a deuterium atom; a halogen atom; a hydroxyl group; a cyano group; a nitro group; an amino group; an amidino group; a hydrazine group; a hydrazone group; a carboxyl group or a salt thereof; a sulfonic acid group or a salt thereof; a phosphoric acid group or a salt thereof; a C1-C10 alkyl group (e.g., a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, or a hexyl group); and a C1-C10 alkoxy group (e.g., a methoxy group, an ethoxy group, a propoxy group, a butoxy group, or a pentoxy group);
a C1-C10 alkyl group and a a C1-C10 alkoxy group, each substituted with at least one of a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphoric acid group or a salt thereof;
a phenyl group; a naphthyl group; an anthryl group; a fluolenyl group; and a pyrenyl group; and
a phenyl group, a naphthyl group, an anthryl group, a fluolenyl group, and a pyrenyl group, each substituted with at least one of a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C10 alkyl group, and a C1-C10 alkoxy group.
In Formula 300, R59 may be one of:
a phenyl group; a naphthyl group; an anthryl group; a biphenyl group; and a pyridyl group; and
a phenyl group, a naphthyl group, an anthryl group, a biphenyl group, and a pyridyl group, each substituted with at least one of a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C1-C20 alkyl group, and a substituted or unsubstituted C1-C20 alkoxy group.
In some embodiments, a compound represented by Formula 300 may be represented by Formula 300A:
In Formula 300A, detailed descriptions about R51, R61, R62, and R59 are as stated above.
In some embodiments, at least one of the HIL 131, the HTL 132, and the H-functional layer may include at least one of Compounds 301 to 320:
The at least one of the HIL 131, the HTL 132, and the H-functional layer may further include a charge-generating material in addition to the HIL material, the HTL material, and/or a material having both hole injecting and transporting capabilities to increase conductivity of the layers.
The charge-generating material may be, for example, one of a quinine derivative, a metal oxide, and a cyano-containing compound. Examples of charge-generating material include quinone derivatives, such as tetra-cyanoquinodimethane (TCNQ) and 2,3,5,6-tetrafluoro-tetracyano-1,4-benzoquinodimethane (F4-TCNQ); metal oxides, such as a tungsten oxide and a molybdenum oxide; and cyano-containing compounds, such as Compound 100 (HAT-CN):
When the HIL 131, the HTL 132, and the H-functional layer further include the charge-generating material, the charge-generating material may be homogeneously or unhomogeneously dispersed in the HIL 131, the HTL 132, and the H-functional layer.
The buffer layer may be disposed between the at least one of the HIL 131, the HTL 132, and the H-functional layer and the EML 133. The buffer layer increases efficiency by compensating an optical resonance distance according the wavelength of light emitted from the EML 133. The buffer layer may include an HIL material and an HTL material. Also, the buffer layer may include the same material as one of the materials included in the HIL 131, the HTL 132, and the H-functional layer formed under the buffer layer.
The EML 133 may be formed on the HIL 131, the HTL 132, the H-functional layer, or the buffer layer by vacuum deposition, spin coating, casting, or LB deposition. When the EML is formed by vacuum deposition or spin coating, the deposition and coating conditions vary according to a used compound, but generally the condition may be about the same as the condition for forming the HIL 131.
The EML 133 may include an EML material. In some embodiments, the EML 133 may include an indenopyridine-based compound represented by Formula 1. The indenopyridine-based compound represented by Formula 1 may serve as a host.
Also, the EML 133 may further include a host and a dopant.
Examples of the host include Alq3, 4,4′-N,N′-dicabazole-biphenyl (CBP), poly(n-vinylcabazole) (PVK), 9,10-di(naphthalene-2-yl)anthracene (DNA), TCTA, 1,3,5-tris(N-phenylbenzimidazole-2-yl)benzene (TPBI), 3-tert-butyl-9,10-di(naphth-2-yl) anthracene (TBADN), E3, and distyrylarylene (DSA), dmCBP (refer to the formula below), and Compounds 501 through 509 below:
Also, the host may be an anthracene-based compound represented by Formula 400 below:
In Formula 400, Ar111 and Ar112 may each independently be a substituted or unsubstituted C5-C60 arylene group; Ar113 through Ar116 may each independently be selected from a substituted or unsubstituted C1-C10 alkyl group and a substituted or unsubstituted C5-C60 aryl group; and g, h, i, and j may each independently be an integer of 0 to 4.
For example, in Formula 400, Ar111 and Ar112 may each independently be:
a phenylene group, a naphthylene group, a phenanthrenylene group or a pyrenylene group; or
a phenylene group, a naphthylene group, a phenanthrenylene group, fluolenyl group, or a pyrenylene group, each substituted with at least one of a phenyl group, a naphthyl group, and an anthryl group.
In Formula 400, g, h, i, and j are each independently an integer of 0, 1, or 2.
In Formula 400, Ar113 to Ar116 may each independently be one of:
a C1-C10 alkyl group substituted with at least one of a phenyl group, a naphthyl group, and an anthryl group;
a phenyl group; a naphthyl group; an anthryl group; a pyrenyl group; a phenathrenyl group; a fluolenyl group;
a phenyl group, a naphthyl group, an anthryl group, a pyrenyl group, a phenathrenyl group, and a fluolenyl group, each substituted with at least one of a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a phenyl group, a naphthyl group, an anthryl group, a pyrenyl group, a phenathrenyl group, and a fluolenyl group; and
In some embodiments, the anthracene-based compound of Formula 400 may be one of the compounds below:
Also, an anthracene-based compound represented by Formula 401 below may be used as the host:
In Formula 401, detailed descriptions of Ar122 through Ar125 may be referred to the description of Ar113 of Formula 400 stated above.
In Formula 401, Ar126 and Ar127 may each independently be a C1-C10 alkyl group (e.g., a methyl group, an ethyl group, or a propyl group).
In Formula 401, k and l may each independently be an integer of 0 to 4. For example, k and l may each independently be 0, 1, or 2.
For example, the anthrecene-based compound of Formula 401 may be one of the following compounds:
For example, a blue dopant may be one of terfluorene and compounds represented by the formulae below:
For example, a red dopant may be one of the compounds below:
For example, a green dopant may be one of the compounds below:
Examples of a dopant included in the EML include the organic metal complexes below:
Also, the dopant may be represented by Formula 100:
In Formula 100, X is selected from a substituted or unsubstituted C9-C10 cycloalkylene group, a substituted or unsubstituted C9-C10 cycloalkenylene group, and a substituted or unsubstituted C9-C60 arylene group; Ar101 and Ar102 are each independently selected from a substituted or unsubstituted C6-C30 aryl group and a substituted or unsubstituted C2-C30 heteroaryl group; and n is an integer of 2 to 4.
In one embodiment, in Formula 100, X may be selected from:
i) an anthracenyl group, a chrysenyl group, a pyrenyl group, and a benzopyrenyl group; and
ii) an anthracenyl group, a chrysenyl group, a pyrenyl group, and a benzopyrenyl group, each substituted with at least one selected from a deuterium atom, a fluorine atom, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, and a tert-butyl group.
In another embodiment, in Formula 100, X may be selected from an anthracenyl group, a chrysenyl group, a pyrenyl group, and a benzopyrenyl group.
In another embodiment, in Formula 100, X may be a pyrenylene group.
In one embodiment, in Formula 100, Ar101 and Ar102 may each independently be selected from:
i) a phenyl group, a naphthyl group, and a biphenyl group; and
ii) a phenyl group, a naphthyl group, and a biphenyl group, each substituted with at least one selected from a deuterium atom, a fluorine atom, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, a tert-butyl group, and a phenyl group.
In another embodiment, in Formula 100, Ar101 and Ar102 may each independently be selected from:
i) a phenyl group and a biphenyl group; and
ii) a phenyl group and a biphenyl group, each substituted with at least one selected from a fluorine atom, a methyl group, and a phenyl group.
In one embodiment, in Formula 100, n may be 2.
In some embodiments, a compound represented by Formula 100 may be one selected from Compounds 101 to 109:
When the EML 133 includes a host and a dopant, an amount of the dopant in the EML 133 may be generally in the range of, for example, about 0.01 to about 15 wt % based on 100 wt % of the host.
A thickness of the EML 133 is in a range of about 200 Å to about 700 Å. Maintaining a thickness of the EML 133 within this range may help provide excellent light-emitting properties without a substantial increase in driving voltage.
When the OLED 100 is a full-color OLED, the EML 133 may be patterned as a red EML, a green EML, and a blue EML depending on a red pixel, a green pixel, and a blue pixel. In an embodiment, the indenopyridine-based compound represented by Formula 1 may be included in the blue EML as a host.
The EML 133 may have a multiple-layered structure, in which a red EML, a green EML, and a blue EML are stacked so as to emit white light, or the EML 133 may have a single-layered structure including all of a red light-emitting material, a green light-emitting material, and a blue light-emitting material. The OLED 100 including the EML 133 may emit light in full-color by further including a red color filter, a green color filter, and a blue color filter.
Next, the ETL 134 may be formed on the EML 133 by vacuum deposition, spin coating, or casting. When the ETL 134 is formed by vacuum deposition or spin coating, the deposition and coating conditions vary depending on a used compound, but generally the conditions may be about the same as the conditions for forming the HIL 131. Exemplary materials for forming the ETL include quinoline derivatives such as tris(8-quinolinolate)aluminum (Alq3), 3-(biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole (TAZ), bis(2-methyl-8-quinolinolato-N1,O8)-(1,1′-biphenyl) (Balq), beryllium bis(benzoquinolin-10-olate) (Bebq2), DNA, Compound 301, Compound 302, and Bphen:
A thickness of the ETL 134 may be in a range of about 100 Å to about 1,000 Å, for example, in a range of about 150 Å to about 500 Å. Maintaining a thickness of the ETL 134 within this range may help provide satisfactory electron transporting properties without a substantial increase in driving voltage.
The ETL 134 may further include a metal-containing material in addition to an electron transporting organic compound. The metal-containing material may include a Li-complex. Examples of the Li-complex may include a lithium quinolate (Liq) or Compound 203:
Also, the EIL 135, which facilitates electron injection from a cathode, may be formed on the ETL 134. Exemplary materials for forming the EIL 135 include LiF, NaCl, CsF, Li2O, or BaO. The deposition condition of the EIL may vary according a used compound, but generally the condition may be about the same as the condition for forming the HIL 131.
A thickness of the EIL 135 may be in a range of about 1 Å to about 100 Å, for example, in a range of about 3 Å to about 90 Å. Maintaining a thickness of the EIL 135 within this range may help provide satisfactory electron injecting properties without a substantial increase in driving voltage.
The second electrode 140 is formed on the organic layer 130. The second electrode 140 may be a cathode, which is an electron injection electrode. In an embodiment, a metal for forming the second electrode 140 may include a metal having low work function, such as metal, an alloy, an electric conducting compound, and mixtures thereof. For example, the second electrode 140 may be formed as a thin film by using lithium (Li), magnesium (Mg), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), or magnesium-silver (Mg—Ag), and may be transparent. In order to obtain a top-emission type OLED, the second electrode 140 may be formed as a transparent electrode by using ITO or IZO.
Also, in an embodiment, a phosphorescent dopant is included in the EML 133, and a hole blocking layer (HBL) may be formed between the ETL 134 and the EML 133 or between the H-functional layer and the EML 133 by vacuum deposition, spin coating, casting or LB deposition to help prevent triplet excitons or holes from being diffused to the ETL 134. When the HBL is formed by vacuum deposition or spin coating, the conditions thereof may vary according to a used compound, but generally the conditions may be about the same as the condition for forming the HIL 131. Exemplary HBL materials include an oxadiazole deriative, a triazole derivative, and a phenanthroline derivative. For example, BCP may be used as a HBL material:
A thickness of the HBL may be in a range of about 20 Å to about 1,000 Å, for example, in a range of about 30 Å to about 300 Å. Maintaining a thickness of the HBL is within this range may help provide excellent hole blocking properties without a substantial increase in driving voltage.
The OLED 100 has been described by referring to
As used herein, examples of the unsubstituted C1-C60 alkyl group (or a C1-C60 alkyl group) include linear or branched C1-C60 alkyl groups such as methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl, and the like. Examples of the substituted C1-C60 alkyl group include a group, in which at least one hydrogen in the unsubstituted C1-C60 alkyl group is substituted with one of
a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, and a C1-C60 alkoxy group;
a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, and a C60 alkoxy group, each substituted with at least one of a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid or a salt thereof, and a phosphoric acid or a salt thereof;
a C3-C10 cycloalkyl group, a C2-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C2-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, and a C2-C60 heteroaryl group;
a C3-C10 cycloalkyl group, a C2-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C2-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, and a C2-C60 heteroaryl group), each substituted with at least one of a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxyl group or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a phenyl group, a naphthyl group, an anthryl group, a fluolenyl group, a dimethylfluolenyl group, a diphenylfluolenyl group, a carbazolyl group, a phenylcarbazolyl group, a pyridyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolyl group, and an isoquinolyl group; and
—N(Q11)(Q12); and —Si(Q13)(Q14)(Q15) (here, Q11 and Q12 are each independently a C6-C60 aryl group or a C2-C60 heteroaryl group, and Q13 to Q15 are each independently a C1-C60 alkyl group, a C1-C60 alkoxy group, a C6-C60 aryl group, or C2-C60 heteroaryl group.
As used herein, the unsubstituted C1-C60 alkoxy group (or C1-C60 alkoxy group) has a formula of —OA (in this regard, A is the unsubstituted C1-C60 alkyl group as described above) and examples thereof include methoxy, ethoxy, isopropyloxy, and the like. At least one hydrogen atom of the unsubstituted C1-C60 alkoxy group may be substituted with the same substituent as in the substituted C1-C60 alkyl group described above.
As used herein, the unsubstituted C2-C60 alkenyl group (or C2-C60 alkenyl group) is interpreted to contain at least one carbon-carbon double bond in the center or at a terminal of the unsubstituted C2-C60 alkyl group. Examples of the unsubstituted C2-C60 alkenyl group include ethenyl, propenyl, butenyl, and the like. At least one hydrogen atom of the C2-C60 alkenyl group may be substituted with the same substituent as in the substituted C1-C60 alkyl group described above.
As used herein, the unsubstituted C2-C60 alkynyl group (or C2-C60 alkynyl group) is interpreted to contain at least one carbon-carbon triple bond in the center or at a terminal of the C2-C60 alkyl group defined above. Examples of the unsubstituted C2-C60 alkynyl group include ethynyl, propynyl, and the like. At least one hydrogen atom of the unsubstituted C2-C60 alkynyl group may be substituted with the same substituent as in the substituted C1-C60 alkyl group described above.
As used herein, the unsubstituted C3-C30 cycloalkyl group indicates a monovalent group of a saturated cyclic hydrocarbon having 3 to 30 carbons. Examples of the unsubstituted C3-C30 cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a cyclooctyl group. At least one hydrogen atom of the unsubstituted C3-C30 cycloalkyl group may be substituted with the same substituent as in the substituted C1-C60 alkyl group described above.
As used herein, the unsubstituted C3-C30 cycloalkenyl group indicates a ring-type unsaturated hydrocarbon group including at least one carbon-carbon double bond, but not an aromatic ring. Examples of the unsubstituted C3-C30 cycloalkenyl group include a cyclopropenyl group, a cyclobutenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a 1,3-cyclohexadienyl group, a 1,4-cyclohexadienyl group, a 2,4-cycloheptadienyl group, and a 1,5-cyclooctadienyl group. At least one hydrogen atom of the unsubstituted C3-C30 cycloalkenyl group may be substituted with the same substituent as in the substituted C1-C60 alkyl group described above.
As used herein, the unsubstituted C6-C60 aryl group indicates a monovalent group having an aromatic carbocyclic system that has 6 to 60 carbon atoms and at least one aromatic ring and the unsubstituted C6-C60 arylene group indicates a divalent group having an aromatic carbocyclic system that has 6 to 60 carbon atoms and at least one aromatic ring. If the C6-C60 aryl group and the C6-C60 arylene group each independently have two or more aromatic rings, the rings may be fused with each other. At least one hydrogen atom of each of the unsubstituted C6-C60 aryl group and the unsubstituted C6-C60 arylene group may be substituted with the same substituent as in the substituted C1-C60 alkyl group described above.
As used herein, examples of the substituted or unsubstituted C6-C60 aryl group include, but not limited to, a phenyl group, a C1-C10 alkylphenyl group (e.g., an ethylphenyl group), a C1-C10 alkylbiphenyl group (e.g., an ethylbiphenyl group), a halophenyl group (e.g., an o-, m- and p-fluorophenyl group, and a dichlorophenyl group), a dicyanophenyl group, a trifluoromethoxyphenyl group, an o-, m-, and p-tolyl group, an o-, m- and p-cumenyl group, a mesityl group, a phenoxyphenyl group, an (α,α-dimethylbenzene)phenyl group, a (N,N′-dimethyl)aminophenyl group, a (N,N′-diphenyeaminophenyl group, a pentalenyl group, an indenyl group, a naphthyl group, a halonaphthyl group (e.g., a fluoronaphthyl group), a C1-C10 alkylnaphthyl group (e.g., a methylnaphthyl group), a C1-C10alkoxynaphthyl group (e.g., a methoxynaphthyl group), an anthracenyl group, an azulenyl group, a heptalenyl group, an acenaphthylenyl group, a phenalenyl group, a fluorenyl group, an anthraquinolinyl group, a methylanthracenyl group, a phenanthrenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, an ethyl-chrysenyl group, a picenyl group, a perylenyl group, a chloroperylenyl group, a pentaphenyl group, a pentacenyl group, a tetraphenylenyl group, a hexaphenyl group, a hexacenyl group, a rubicenyl group, a coroneryl group, a trinaphthylenyl group, a heptaphenyl group, a heptacenyl, a pyranthrenyl group, and an ovalenyl group. Examples of the substituted C6-C60 aryl group may be easily understood with reference to the examples of the unsubstituted C6-C60 aryl group described above and the substituents of the substituted C1-C60 alkyl group. Examples of the substituted or unsubstituted C6-C60 arylene group may be easily understood with reference to the substituted or unsubstituted C6-C60 aryl group described above.
As used herein, the unsubstituted C2-C60 heteroaryl group indicates a monovalent group having at least one aromatic ring system including carbon rings and at least one hetero atom selected from the group consisting of N, O, P, and S as a ring-forming atom, and the unsubstituted C2-C60 heteroarylene group indicates a divalent group having at least one aromatic ring system including carbon rings and at least one hetero atom selected from the group consisting of N, O, P, and S. In this regard, if the C2-C60 heteroaryl group and the C2-C60 heteroarylene group each independently have two or more aromatic rings, the rings may be fused with each other. At least one hydrogen atom of each of the unsubstituted C2-C60 heteroaryl group and the unsubstituted C2-C60 heteroarylene group may be substituted with the same substituents as in the C1-C60 alkyl group described above.
As used herein, examples of the unsubstituted C2-C60 heteroaryl group include, but not limited to, a pyrazolyl group, an imidazolyl group, an oxazolyl group, a thiazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a pyridinyl group, a pyridazinyl group, a pyrimidinyl group, a triazinyl group, a carbazolyl group, an indolyl group, a quinolinyl group, an isoquinolinyl group, a benzoimidazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group. Examples of the unsubstituted C2-C60 heteroarylene group may be easily understood with reference to the examples of the substituted or unsubstituted C2-C60 arylene group.
The substituted or unsubstituted C6-C60 aryloxy group has a formula of —OA2, wherein A2 is the substituted or unsubstituted C6-C60 aryl group as described above, and the substituted or unsubstituted C6-C60 arylthio group has a formula of —SA3, wherein A3 is the substituted or unsubstituted C6-C60 aryl group described above.
The following Examples and Comparative Examples are provided in order to highlight characteristics of one or more embodiments, but it will be understood that the Examples and Comparative Examples are not to be construed as limiting the scope of the embodiments, nor are the Comparative Examples to be construed as being outside the scope of the embodiments. Further, it will be understood that the embodiments are not limited to the particular details described in the Examples and Comparative Examples.
EXAMPLES Synthesis Example 1 Synthesis of Compound 15 g (1 eq, 29.06 mmol) of 2-bromo-3-methylpyridine, 6.12 g (1.05 eq, 30.52 mmol) 4-bromophenylboronic acid, and 1.34 g (0.04 eq, 1.16 mmol) of tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) were put into a reaction flask and vacuum-dried, and the flask was filled with nitrogen gas. 72 ml of toluene was added into the reaction flask to dissolve the compounds. Then, 36 ml of ethanol and 36 ml (2.5 eq, 72.65 mmol) of 2.0 M sodium carbonate aqueous solution were added thereto, and the mixture was stirred while refluxing at a temperature of 120° C. for 3 hours. After the reaction was completed, the resultant solution was washed with distilled water, and an organic layer was extracted and collected using ethyl acetate. The collected anhydrous organic layer was dried by using anhydrous sulfur magnesium, and the solvent was removed therefrom by distillation under reduced pressure. The residue obtained therefrom was purified through a silica gel column chromatography to obtain 4.5 g (yield: 60%) of Intermediate 1. Intermediate 1 was confirmed by using NMR and APCI-MS.
1H-NMR δ(ppm): 8.50 (d, 1H), 7.60 (d, 3H), 7.42 (td, 2H), 7.19 (d, 1H), 2.32 (s, 3H)
APCI-MS (m/z): 248[M+]
Synthesis of Intermediate 25.88 g (1 eq, 21.14 mmol) of 2-(4-bromophenyl)nicotinic acid, which was quantitatively obtained by reacting Intermediate 1 with a KMnO4 aqueous solution, was put into a reaction flask, and 30 g of polyphosphoric acid was added thereto. After the reaction was completed, the resulting solution was added into a beaker containing 5 N sodium hydroxide aqueous solution, stirred at room temperature, and filtered the mixture to obtain 3.3 g (yield: 60%) of Intermediate 2 as a yellow solid. Intermediate 2 was confirmed by using NMR and APCI-MS.
1H-NMR δ(ppm): 7.92 (d, 1H), 7.86 (s, 1H), 7.74 (d, 2H), 7.25 (d, 1H)
APCI-MS (m/z): 260[M+]
Synthesis of Intermediate 33.29 g (1 eq, 14.09 mmol) of 2-bromobiphenyl was put into a reaction flask and dissolved with 150 ml of THF. 4.67 ml (14.09 eq, 8.78 mmol) of 1.6 M n-BuLi was slowly and added drop wise to the reaction flask at a temperature of −78° C. After stirring at a temperature of −78° C. for 30 minutes, 3.3 g (0.9 eq, 12.69 mmol) of Intermediate 2 was added thereto, and then stirred at room temperature for 5 minutes. After the reaction was completed, the resultant solution was washed with distilled water, and an organic layer was extracted and collected using ethyl acetate. The residue obtained from the collected organic layer by removing the solvent was put into a flask, and 5 ml of MeSO3H was slowly and added drop wise thereto. The reaction solution was extracted with ethyl acetate, and an organic layer was collected. The collected anhydrous organic layer was dried by using anhydrous sulfur magnesium, and the solvent was removed therefrom by distillation under reduced pressure. The residue obtained therefrom was purified through a silica gel column chromatography to obtain 3.4 g (yield: 70%) of Intermediate 3. Intermediate 2 was confirmed by using NMR and APCI-MS.
1H-NMR δ(ppm): 8.59 (t, 1H), 8.00 (d, 1H), 7.85 (d, 2H), 7.57 (dd, 1H), 7.41 (t, 2H), 7.17 (t, 2H), 7.06 (d, 2H), 6.90 (s, 1H), 6.74 (d, 2H)
APCI-MS (m/z): 396[M+]
Synthesis of Compound 13.4 g (1 eq, 8.57 mmol) of Intermediate 3, 2.81 g (1.03 eq, 9.43 mmol) of 9-phenylanthracen-10-ylboronic acid, and 396 mg (0.04 eq, 0.343 mmol) Pd(PPh3)4 were put into a reaction flask and vacuum-dried, and the flask was filled with nitrogen gas. 40 ml of toluene was added into the reaction flask to dissolve the compounds. Then, 15 ml of ethanol and 15 ml (2.5 eq, 21.4 mmol) of 2.0 M sodium carbonate aqueous solution were added thereto, and the mixture was stirred while refluxing at a temperature of 120° C. for 3 hours. After the reaction was completed, the resultant solution was washed with distilled water, and an organic layer was extracted and collected using ethyl acetate. The collected anhydrous organic layer was dried by using anhydrous sulfur magnesium, and the solvent was removed therefrom by distillation under reduced pressure. The residue obtained therefrom was purified through a silica gel column chromatography to obtain 3.8 g (yield: 78%) of Compound 1. Compound 1 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 8.68 (d, 1H), 8.39 (d, 1H), 7.75 (d, 2H), 7.58 (m, 10H), 7.47 (d, 1H), 7.34 (m, 4H), 7.24 (d, 2H), 7.15 (m, 4H), 6.87 (m, 2H)
APCI-MS (m/z): 569[M+]
Synthesis Example 2 Synthesis of Compound 22.83 g (1 eq, 29.06 mmol) of methyl 2-chloronicotinate, 6.12 g (1.05 eq, 30.52 mmol) of 4-bromophenylboronic acid, and 1.34 g (0.04 eq, 1.16 mmol) of Pd(PPh3)4 were put into a reaction flask and vacuum-dried, and the flask was filled with nitrogen gas. 72 ml of toluene was added into the reaction flask to dissolve the compounds. Then, 36 ml of ethanol and 36 ml (2.5 eq, 72.65 mmol) of 2.0 M sodium carbonate aqueous solution were added thereto, and the mixture was stirred while refluxing at a temperature of 120° C. for 3 hours. After the reaction was completed, the resultant solution was washed with distilled water, and an organic layer was extracted and collected using ethyl acetate. The collected anhydrous organic layer was dried by using anhydrous sulfur magnesium, and the solvent was removed therefrom by distillation under reduced pressure. The residue obtained therefrom was purified through a silica gel column chromatography to obtain 3.37 g (yield: 60%) of Intermediate 4. Intermediate 4 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 8.78 (dd, 1H), 8.12 (dd, 1H), 7.58 (d, 2H), 7.42 (d, 2H), 7.34 (d, 1H)
APCI-MS (m/z): 292[M+]
Synthesis of Intermediate 53.37 g (1 eq, 11.54 mmol) of Intermediate 4 was put into a reaction flask and vacuum-dried, and the flask was filled with nitrogen gas. 100 ml of THF was added thereto, and then 9.6 ml (2.5 eq, 28.84 mmol) of 3.0 M methylmagnesium chloride (CH3MgCl) was slowly and added drop wise thereto. After the reaction was completed, the reaction solution was extracted with ethyl acetate, and an organic layer was collected. The collected anhydrous organic layer was dried by using anhydrous sulfur magnesium, and the solvent was removed therefrom by distillation under reduced pressure. The residue obtained therefrom was put into a flask, 30 g of polyphosphoric acid was added thereto, and then the mixture was stirred while refluxing at a temperature of 190° C. After the reaction was completed, the reaction solution was extracted with ethyl acetate, and an organic layer was collected. The collected anhydrous organic layer was dried by using anhydrous sulfur magnesium, and the solvent was removed therefrom by distillation under reduced pressure. The obtained residue was purified through a silica gel column chromatography to obtain 1.6 g (yield: 70%) of Intermediate 5. Intermediate 5 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 8.56 (d, 1H), 7.88 (d, 1H), 7.72 (d, 1H), 7.62 (s, 1H), 7.56 (dd, 1H), 7.22 (dd, 1H), 1.50 (s, 6H)
APCI-MS (m/z): 274[M+]
Synthesis of Compound 21.6 g (1 eq, 5.83 mmol) of Intermediate 5, 1.91 g (1.1 eq, 6.42 mmol) of 9-phenylanthracen-10-ylboronic acid, and 270 mg (0.04 eq, 0.23 mmol) of Pd(PPh3)4 were put into a reaction flask and vacuum-dried, and the flask was filled with nitrogen gas. 20 ml of toluene was added into the reaction flask to dissolve the compounds. Then, 9 ml of ethanol and 9 ml (3 eq, 17.5 mmol) of 2.0 M sodium carbonate aqueous solution were added thereto, and the mixture was stirred while refluxing at a temperature of 120° C. for 3 hours. After the reaction was completed, the resultant solution was washed with distilled water, and an organic layer was extracted and collected using ethyl acetate. The collected anhydrous organic layer was dried by using anhydrous sulfur magnesium, and the solvent was removed therefrom by distillation under reduced pressure. The residue obtained therefrom was purified through a silica gel column chromatography to obtain 1.7 g (yield: 65%) of Compound 2. Compound 2 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 8.64 (dd, 1H), 8.27 (d, 1H), 7.73 (m, 5H), 7.55 (m, 7H), 7.36 (m, 4H), 7.27 (t, 1H), 1.54 (s, 6H)
APCI-MS (m/z): 447[M+]
Synthesis Example 3 Synthesis of Compound 3Intermediate 6 was synthesized in the same manner as in the synthesis of Intermediate 1, except that 2-bromophenyl boronic acid was used instead of 4-bromobiphenyl. Intermediate 6 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 8.53 (d, 1H), 7.67 (d, 1H), 7.60 (d, 1H), 7.40 (t, 1H), 7.29 (m, 2H), 7.22 (m, 1H), 2.16 (s, 3H)
APCI-MS (m/z): 248[M+]
Synthesis of Intermediate 73 g (yield: 89%) of Intermediate 7 was synthesized in the same manner as in the synthesis of Intermediate 2, except that Intermediate 6 was used instead of Intermediate 1. Intermediate 7 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 8.80 (dd, 1H), 7.94 (d, 1H), 7.76 (d, 1H), 7.72 (d, 1H), 7.29 (m, 2H)
APCI-MS (m/z): 260[M+]
Synthesis of Intermediate 82.6 g (yield: 90%) of Intermediate 8 was synthesized in the same manner as in the synthesis of Intermediate 3, except that Intermediate 7 was used instead of Intermediate 2. Intermediate 8 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 8.76 (d, 1H), 7.85 (d, 2H), 7.60 (d, 1H), 7.40 (t, 214), 7.15 (t, 2H), 7.08 (m, 3H), 6.70 (t, 3H)
APCI-MS (m/z): 396[M+]
Synthesis of Compound 31.72 g (yield: 61%) of Compound 3 was synthesized in the same manner as in the synthesis of Compound 1, except that Intermediate 8 was used instead of Intermediate 3. Compound 3 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 7.90 (d, 2H), 7.85 (dd, 1H), 7.78 (m, 4H), 7.64 (m, 5H), 7.42 (t, 2H), 7.38 (m, 6H), 7.22 (d, 2H), 6.94 (m, 4H), 6.68 (dd, 1H)
APCI-MS (m/z): 569[M+]
Synthesis Example 4 Synthesis of Compound 43.25 g (yield: 47%) of Intermediate 9 was synthesized in the same manner as in the synthesis of Intermediate 4, except that 2-bromophenyl boronic acid was used instead of 4-bromobiphenyl boronic acid. Intermediate 9 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 8.83 (d, 1H), 8.35 (d, 1H), 7.63 (d, 1H), 7.45-7.38 (m, 3H), 7.29 (d, 1H), 3.71 (s, 3H)
APCI-MS (m/z): 292[M+]
Synthesis of Intermediate 101.13 g (yield: 60%) of Intermediate 10 was synthesized in the same manner as in the synthesis of Intermediate 5, except that Intermediate 9 was used instead of Intermediate 4, and CH3MgBr was used instead of CH3MgCl. Intermediate 10 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 8.73 (dd, 1H), 7.74 (dd, 1H), 7.60 (dd, 1H), 7.45 (dd, 1H), 7.29-7.23 (m, 2H), 1.48 (s, 6H)
APCI-MS (m/z): 274[M+]
Synthesis of Compound 41.82 g (yield: 76%) of Compound 4 was synthesized in the same manner as in the synthesis of Compound 2, except that Intermediate 10 was used instead of Intermediate 5. Compound 4 was confirmed by using 1H-NMR and APCI-MS.
1H-NMR δ(ppm): 7.82 (dd, 1H), 7.74 (d, 2H), 7.70−7.50 (m, 10H), 7.34−7.16 (m, 5H), 6.88 (dd, 1H), 1.64 (s, 6H)
APCI-MS (m/z): 447[M+]
Example 1As an anode, a 15 Ω/cm2 (1200 Å) ITO glass substrate was cut to a size of 50 mm×50 mm×0.7 mm, washed with ultrasonic waves in isopropyl alcohol and pure water for 5 minutes each, and then cleaned with UV for 30 minutes and ozone for 10 minutes. The ITO glass substrate was mounted on a vacuum depositor.
4,4′,4″-tris[2-naphthyl(phenyl)amino]triphenylamine (2-TNATA) was deposited on the ITO glass substrate to form a HIL having a thickness of 600 Å and 4,4′-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (NPB) was then deposited on the HIL to form a HTL having a thickness of 300 Å.
Then, Compound 1 (as a host) and Compound 102 (as a dopant) were co-deposited on the HTL at a weight ratio of 95:5 to form an EML having a thickness of 200 Å.
Then, Compound 201 was vacuum-deposited on the EML to form an ETL having a thickness of 300 Å, LiF was deposited on the ETL to form an EIL having a thickness of 10 Å, and Al was deposited on the EIL to form a cathode having a thickness of 3,000 Å, thereby completing the manufacture of an OLED.
An OLED was manufactured in the same manner as in Example 1, except that Compound 2 was used instead of Compound 1 in the formation of the EML.
Example 3An OLED was manufactured in the same manner as in Example 1, except that Compound 3 was used instead of Compound 1 in the formation of the EML.
Example 4An OLED was manufactured in the same manner as in Example 1, except that Compound 4 was used instead of Compound 1 in the formation of the EML.
Comparative Example 1An OLED was manufactured in the same manner as in Example 1, except that 9,10-di(naphthalen-2-yl)anthracene (ADN) was used instead of Compound 1 in the formation of the EML.
Comparative Example 2An OLED was manufactured in the same manner as in Example 1, except that Compound X was used instead of Compound 102 in the formation of the EML.
An OLED was manufactured in the same manner as in Example 1, except that Compound A was used instead of Compound 1 in the formation of the EML.
An OLED was manufactured in the same manner as in Example 1, except that Compound B was used instead of Compound 1 in the formation of the EML.
Driving voltage, brightness, and efficiency of the OLEDs of Examples 1 through 4 and Comparative Examples 1 through 4 were evaluated using a current-voltmeter, Kethley SMU 236 (available from PhotoResearch), to apply a voltage to the OLEDs, and the results are shown in Table 1 below.
Referring to Table 1, the OLEDs of Examples 1 through 4 exhibit excellent driving voltage, high brightness, and higher efficiency, as compared to the OLEDs of Comparative Examples 1 through 4.
By way of summation and review, an OLED structure may include a substrate, an anode, a hole transport layer (HTL), an emission layer (EML), an electron transport layer (ETL), and a cathode, which are sequentially stacked on the substrate. The HTL, the EML, and the ETL are organic layers formed of organic compounds.
When a voltage is applied between the anode and the cathode, holes injected from the anode move to the EML via the HTL, and electrons injected from the cathode move to the EML via the ETL. The holes and electrons are recombined with each other in the EML to generate excitons. Then, the excitons are transitioned from an excited state to a ground state, thereby generating light.
As described above, according to one or more embodiments, an OLED of high quality may be provided.
Example embodiments have been disclosed herein, and although specific terms are employed, they are used and are to be interpreted in a generic and descriptive sense only and not for purpose of limitation. In some instances, as would be apparent to one of ordinary skill in the art as of the filing of the present application, features, characteristics, and/or elements described in connection with a particular embodiment may be used singly or in combination with features, characteristics, and/or elements described in connection with other embodiments unless otherwise specifically indicated. Accordingly, it will be understood by those of skill in the art that various changes in form and details may be made without departing from the spirit and scope of the present invention as set forth in the following claims.
Claims
1. An indenopyridine-based compound represented by Formula 1:
- wherein, in Formula 1,
- X1 is a nitrogen atom (N) or C(R11); X2 is N or C(R12); X3 is N or C(R13); X4 is N or C(R14); wherein at least one of X1 to X4 is N;
- L1 is selected from a substituted or unsubstituted C3-C10 cycloalkylene group, a substituted or unsubstituted C3-C10 cycloalkenylene group, a substituted or unsubstituted C6-C60 arylene group, a substituted or unsubstituted C2-C10 heterocycloalkylene group, a substituted or unsubstituted C2-C10 heterocycloalkenylene group, and a substituted or unsubstituted C2-C60 heteroarylene group;
- n1 is selected from an integer of 0, 1, 2, and 3;
- R1 and R2 are each independently selected from a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, a carboxyl group, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C2-C30 alkenyl group, a substituted or unsubstituted C2-C30 alkynyl group, a substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C6-C30 arylthio group, and a substituted or unsubstituted C2-C30 heteroaryl group, wherein R1 and R2 are optionally connected to each other to form a substituted or unsubstituted C6-C20 saturated ring or a substituted or unsubstituted C6-C20 unsaturated ring;
- R11 to R14, R3, and R4 are each independently selected from a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, a carboxyl group, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C2-C30 alkenyl group, a substituted or unsubstituted C2-C30 alkynyl group, a substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C6-C30 arylthio group, and a substituted or unsubstituted C2-C30 heteroaryl group; and
- a1 and a2 are each independently selected from an integer of 0, 1, 2 and 3.
2. The indenopyridine-based compound as claimed in claim 1, wherein L1 is selected from
- i) a phenylene group, an anthracenylene group, a chrysenylene group, and a pyrenylene group; and
- ii) a phenylene group, an anthracenylene group, a chrysenylene group, and a pyrenylene group, each substituted with at least one selected from
- a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, and a tert-butyl group;
- a phenyl group, a naphthyl group, a pyridyl group, and a triazinyl group; and
- a phenyl group, a naphthyl group, a pyridyl group, and a triazinyl group, each substituted with at least one selected from a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, and a tert-butyl group.
3. The indenopyridine-based compound as claimed in claim 1, wherein L1 is selected from a phenylene group, an anthracenylene group, a chrysenylene group, and a pyrenylene group.
4. The indenopyridine-based compound as claimed in claim 1, wherein n1 is an integer of 1 or 2.
5. The indenopyridine-based compound as claimed in claim 1, wherein a moiety represented by (L1)n1 is one selected from Formulae 3-1 to 3-4:
- wherein, in Formulae 3-1 to 3-4,
- * is a binding site with R4, and
- ** is a binding site with an indenopyridine ring.
6. The indenopyridine-based compound as claimed in claim 1, wherein R1 and R2 are each independently selected from a hydrogen atom, a deuterium atom, a methyl group, and a phenyl group, or R1 and R2 combined are Formula 5:
- wherein, in Formula 5,
- * is a binding site with an indenopyridine ring.
7. The indenopyridine-based compound as claimed in claim 1, wherein R11 to R14, and R3 are each independently selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a nitro group, and a methyl group.
8. The indenopyridine-based compound as claimed in claim 1, wherein R4 is selected from:
- i) a phenyl group, a naphthyl group, and an anthryl group; and
- ii) a phenyl group, a naphthyl group, and an anthryl group, each substituted with at least one selected from a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, a tert-butyl group, a phenyl group, a naphthyl group, and an anthryl group.
9. The indenopyridine-based compound as claimed in claim 1, wherein R4 is selected from a phenyl group, a 1-naphthyl group, and a 2-naphthyl group.
10. The indenopyridine-based compound as claimed in claim 1, wherein a2 is an integer of 0 or 1.
11. The indenopyridine-based compound as claimed in claim 1, wherein:
- a2 is 1 or n1 is 1; and
- a1 is 3.
12. The indenopyridine-based compound as claimed in claim 1, wherein the indenopyridine-based compound is represented by Formula 1a:
- wherein, in Formula 1a,
- a moiety represented by (L1)n1 is one selected from Formulae 3-1 to 3-4:
- wherein, in Formulae 3-1 to 3-4, * is a binding site with R4, and ** is a binding site with an indenopyridine ring;
- R1 and R2 are each independently selected from a hydrogen atom, a deuterium atom, a methyl group, and a phenyl group, or R1 and R2 combined are Formula 5:
- wherein, in Formula 5, * is a binding site with an indenopyridine ring;
- R3 and R12 to R14 are each independently selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a nitro group, and a methyl group;
- R4 is selected from a phenyl group, a 1-naphthyl group, and a 2-naphthyl group;
- a1 is 3; and
- a2 is an integer of 0 or 1.
13. The indenopyridine-based compound as claimed in claim 1, wherein the indenopyridine-based compound is represented by one of Formulae 1b to 1e:
- wherein, in Formulae 1 b to 1 e,
- a moiety represented by (L1)n1 is one selected from Formulae 3-1 to 3-4:
- wherein, in Formulae 3-1 to 3-4, * is a binding site with R4, and ** is a binding site with an indenopyridine ring;
- R1 and R2 are each independently selected from a hydrogen atom, a deuterium atom, a methyl group, and a phenyl group, or R1 and R2 combined are Formula 5:
- wherein, in Formula 5, * is a binding site with an indenopyridine ring;
- R13 is selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a nitro group, and a methyl group;
- R4 is selected from a phenyl group, a 1-naphthyl group, and a 2-naphthyl group; and
- a2 is an integer of 0 or 1.
14. The indenopyridine-based compound as claimed in claim 1, wherein the indenopyridine-based compound represented by Formula 1 is one selected from Compounds 1 to 25:
15. An organic light-emitting device (OLED), comprising:
- a first electrode;
- a second electrode facing the first electrode; and
- an organic layer that is disposed between the first electrode and the second electrode and includes an emission layer,
- wherein the organic layer includes at least one indenopyridine-based compound of claim 1.
16. The OLED as claimed in claim 15, wherein the organic layer further includes a hole transporting region including at least one selected from a hole injection layer, a hole transport layer, a functional layer having both hole injecting and transporting capabilities, a buffer layer, and an electron blocking layer between the first electrode and the emission layer, and further includes an electron transporting region including at least one selected from a hole blocking layer, an electron transport layer, and an electron injection layer between the emission layer and the second electrode.
17. The OLED as claimed in claim 15, wherein the emission layer includes the indenopyridine-based compound.
18. The OLED as claimed in claim 17, wherein the emission layer further includes a dopant, and the indenopyridine-based compound serves as a host.
19. The OLED as claimed in claim 18, wherein the dopant is an amine-based compound represented by Formula 100:
- wherein, in Formula 100,
- X is selected from an anthracenyl group, a chrysenyl group, a pyrenyl group, and a benzopyrenyl group;
- Ar101 and Ar102 are each independently selected from
- i) a phenyl group, a naphthyl group, and a biphenyl group; and
- ii) a phenyl group, a naphthyl group, and a biphenyl group, each substituted with at least one of a deuterium atom, a fluorine atom, a cyano group, a nitro group, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, a tert-butyl group, and a phenyl group; and
- n is an integer of 2 to 4.
20. The OLED as claimed in claim 18, wherein the dopant is one selected from Compounds 101 to 109:
Type: Application
Filed: Aug 12, 2014
Publication Date: Mar 5, 2015
Patent Grant number: 10134997
Inventors: Soung-Wook KIM (Yongin-City), Myeong-Suk KIM (Yongin-City), Jae-Hong KIM (Yongin-City), Sam-Il KHO (Yongin-City), Seung-Soo YOON (Yongin-City)
Application Number: 14/457,533
International Classification: H01L 51/50 (20060101); H01L 51/00 (20060101);
